Clinical Data Research
Biostatistics
Epidemiologic Methods
Environmental Sciences
Clinical Medicine and Nephrology

Dr. Ping-Chin Lai specializes in the diagnosis and treatment of kidney diseases; including kidney transplantation, acute and chronic kidney disease, hemodialysis, peritoneal dialysis, hypertension, and diabetes. Dean Lai has extensive experience in kidney transplantation and is good at other kidney-related diseases. Kidney disease usually manifests in hematuria, proteinuria, electrolyte abnormalities, edema, and accompanying hypertension; patients with chronic renal failure (referred to as chronic renal failure) must be considered for hemodialysis, peritoneal dialysis, or kidney transplantation.

Prof. Chung-Liang Lan was the first Taiwan rheumatology fellow trained at the Johns Hopkins Medical Center in the United States in 1970s. With over 50 years of professional experience, he was honored with the Master Award by the Taiwan Rheumatology Association in 2013 and the Asia Pacific League of Associations for Rheumatology (APLAR) in 2017. He also served as the President of the Taiwan College of Rheumatology (TCR) from 2009 to 2011.Currently, he serves as an Advisor to the Superintendent's Office at China Medical University Hospital and as a Chair Professor at China Medical University. His research areas include autoimmune diseases (focus on SLE and RA) and connective tissue diseases complicated by interstitial lung disease. His research team focuses primarily on developing novel diagnostic markers and prognostic markers for the progression of interstitial lung disease. Over the past 40 years, he has served as the principal investigator for at least 80 multinational clinical trials for new drugs (Phases I-III), with his patient enrollment numbers and trial quality frequently ranking at the top globally.

Prof. Chen is the Vice Dean of the Department of Medicine at CMUH and former Vice Superintendent and Director of the Center (2017–2025), is among Taiwan's most influential rheumatologists. Dr. Der-Yuan Chen is a specialist in allergy, immunology, and rheumatology with over 40 years of professional experience. He was honored with the Master Award by the Taiwan Rheumatology Association (2023) and the Asia Pacific League of Associations for Rheumatology (2024), and he previously served as the President of the TCR (2014–2016). He currently serves as the Vice Superintendent and the Director of the Rheumatology and Immunology Center at China Medical University Hospital. His research areas include the immunopathogenesis of autoimmune diseases (such as SLE and RA) and autoinflammatory diseases (AOSD), the association between infection and immune inflammation, and the safety of targeted therapies. In recognition of his outstanding achievements in SLE research, he received the Academic Research Award from Taiwan's Society of Immunology and participated in formulating the Asia-Pacific recommendations for the management of SLE (Lancet Rheumatology, 2022). His exceptional research on AOSD has yielded 35 SCI papers that have been frequently cited in rheumatology textbooks, earning him the prestigious distinction of being named among the World's Top 2% Scientists in 2020,2021,2024 and 2025. As of 2024, he has published 262 SCI journal papers, accumulating over 11,000 citations.

Dr.Chang studied for a year at National Taiwan University in the Department of Endocrinology and Metabolism and another one year at UCLA in the United States. He has served as the Director of the Endocrinology and Metabolism Department and the Deputy Director of the Internal Medicine Department at China Medical University Hospital. Dr. Chang's clinical and research interests include the treatment of diabetes and thyroid diseases, particularly the clinical interpretation of thyroid ultrasound for predicting malignant tumors.

Dr. Su-Peng Yeh served as the Secretary-General of the Taiwanese Society of Hematopoietic Stem Cell Transplantation and has been an Executive Director of the Society since 2010. He is currently the Vice Superintendent of the Department of Internal Medicine at our hospital. Dr. Yeh specializes in hematopoietic stem cell (bone marrow) transplantation, with over 100 successful transplant cases under his belt. He is also proficient in various cancer chemotherapies and transfusion medicine. In 2006, Dr. Yeh spent a year at MD Anderson Cancer Center in the United States, focusing his research on gene therapy for breast cancer. Furthermore, Dr. Yeh actively participates in numerous clinical trials for hematologic malignancies and rare blood disorders. He is a key member of the Steering Committee for several of these trials and is the physician with the most extensive experience in CAR-T cell therapy at our hospital.

Chang-Fang Chiu, M.D., Ph.D., is currently the Director of the Cancer Center at China Medical University Hospital. He completed his training at the renowned Memorial Sloan Kettering Cancer Center in New York, USA. Dr. Chiu possesses extensive experience in the diagnosis and treatment of various malignant tumors and hematological diseases. He established a patient-centered, multidisciplinary team approach to care, which is applied to over twenty major cancer types. He also built a comprehensive hematopoietic stem cell transplantation care system, dedicated to providing patients with high-quality medical care.

Geriatric Medicine Family Medicine Preventive Community Medicine Health Services Administration

Family Medicine Bariatric Medicine Geriatric Medicine Human Nutrition Hospice Palliative Group Counselling Health and Travel Medicine

Professor Tsai is the current Dean of the College of Medicine at China Medical University and the Director of the Neurology Department at its affiliated hospital. He has served as the President of the Taiwan Movement Disorder Society and as a council member of the International Parkinson's and Movement Disorder Society for the Asia-Pacific region. Professor Tsai is an expert in clinical neurophysiology and involuntary movement disorders, specializing in the application of neurophysiological modulation and focused ultrasound treatment for Parkinson's patients. In addition to his clinical work and research, he is also deeply committed to medical education. He was awarded the 2020 Taiwan Medical Model Award.